These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25564812)

  • 1. Role of transjugular intrahepatic portosystemic shunt in children with advanced intestinal failure associated liver disease and portal hypertension.
    Wells LB; Mangat K; Gupte GL
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):e38-9. PubMed ID: 25564812
    [No Abstract]   [Full Text] [Related]  

  • 2. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
    Therapondos G; Wong F
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?
    Riggio O; Ridola L; Lucidi C; Angeloni S
    Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease?
    Forster J; Siegel EL; Delcore R; Payne KM; Laurin J; Kindscher JD
    Am J Surg; 1996 Nov; 172(5):536-9; discussion 539-40. PubMed ID: 8942559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation?
    Valdivieso A; Ventoso A; Gastaca M; Bustamante J; Aguinaga A; Ruiz P; Gonzalez-Uriarte J; Martínez-Indart L; Testillano M; Fernández JR; Muñoz F; Montejo M; Matarranz A; Suárez MJ; Ortiz de Urbina J
    Transplant Proc; 2012; 44(6):1505-7. PubMed ID: 22841197
    [No Abstract]   [Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt: current indications, patient selection and results.
    Goykhman Y; Ben-Haim M; Rosen G; Carmiel-Haggai M; Oren R; Nakache R; Szold O; Klausner J; Kori I
    Isr Med Assoc J; 2010 Nov; 12(11):687-91. PubMed ID: 21243870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvenous intrahepatic portosystemic shunts.
    Kamath PS; McKusick MA
    Gastroenterology; 1996 Dec; 111(6):1700-5. PubMed ID: 8942752
    [No Abstract]   [Full Text] [Related]  

  • 10. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension.
    Boyer TD; Haskal ZJ
    J Vasc Interv Radiol; 2005 May; 16(5):615-29. PubMed ID: 15872315
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Boyer TD; Haskal ZJ;
    Hepatology; 2005 Feb; 41(2):386-400. PubMed ID: 15660434
    [No Abstract]   [Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt in an infant.
    Sergent G; Gottrand F; Delemazure O; Ernst O; Bonvarlet P; Mizrahi D; L'Hermine C
    Pediatr Radiol; 1997 Jul; 27(7):588-90. PubMed ID: 9211953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transjugular intrahepatic portosystemic shunt in treatment of portal hypertension].
    Tarazov PG
    Khirurgiia (Mosk); 1999; (7):64-9. PubMed ID: 10459195
    [No Abstract]   [Full Text] [Related]  

  • 14. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009.
    Boyer TD; Haskal ZJ;
    Hepatology; 2010 Jan; 51(1):306. PubMed ID: 19902484
    [No Abstract]   [Full Text] [Related]  

  • 15. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What role for transjugular intrahepatic portosystemic shunt?
    García L
    Rev Esp Enferm Dig; 2000 Apr; 92(4):193-8. PubMed ID: 10939789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transjugular intrahepatic portosystemic shunt (TIPS). Therapeutic alternative in refractory ascites and varicose bleeding].
    Olin M; Ivancev K; Verbaan H
    Lakartidningen; 2008 Sep 10-16; 105(37):2490-4. PubMed ID: 19006865
    [No Abstract]   [Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma.
    Fanelli F; Angeloni S; Salvatori FM; Marzano C; Boatta E; Merli M; Rossi P; Attili AF; Ridola L; Cerini F; Riggio O
    Dig Liver Dis; 2011 Jan; 43(1):78-84. PubMed ID: 20637712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent position of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
    Svoboda P; Kantorova I; Brhelova H; Vasickova J; Ochmann J
    Hepatogastroenterology; 1997; 44(15):647-55. PubMed ID: 9222665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Riggio O; Nardelli S; Moscucci F; Pasquale C; Ridola L; Merli M
    Clin Liver Dis; 2012 Feb; 16(1):133-46. PubMed ID: 22321469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.